Fundamental Flaws in Pfizer’s COVID-19 Vaccine Submission
Reference: Oldfield, P. R., & Gutschi, M. L. (2022). Fundamental flaws in Pfizer’s COVID-19 biologics license application submission, and the implications to the safety and effectiveness of these novel gene therapy vaccines. Canadian COVID Care Alliance. Retrieved from https://www.canadiancovidcarealliance.org/ Summary: The article critiques Pfizer’s COVID-19 vaccine approval process, highlighting significant flaws in the Biologics License […]